DAA935 |
Pro-B cell generation and differentiation declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
DAA1073 |
Fewer cells and higher apoptosis |
Physiological |
bone marrow |
Human |
— |
— |
|
DAA934 |
Number of mature B cells leaving the bone marrow declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|
DAA673 |
telomere length in hematopoietic stem cells |
Molecular |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2027 |
DNA damage acummulates in hematopoietic stem and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA932 |
Renewal capacity declines |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2014 |
Microsatellite instability in hematopoietic stem cells and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
MLH1 |
— |
|
DAA1991 |
Hematopoietic cells accumulate random mutations |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2441 |
complement factor D preproprotein increases with age |
Molecular |
mesenchymal stem cell |
Human |
CFD |
22.2% Increase DNA Methylation |
|
DAA2433 |
cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CDKN2B |
16.7% Decrease DNA Methylation |
|
DAA2437 |
dehydrogenase/reductase (SDR family) member 3 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
DHRS3 |
18.6% Decrease DNA Methylation |
|
DAA2460 |
gelsolin-like capping protein decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPG |
19.3% Decrease DNA Methylation |
|
DAA2452 |
homeo box B1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
HOXB1 |
49.3% Decrease DNA Methylation |
|
DAA2453 |
hypothetical protein LOC126353 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MISP |
24.8% Decrease DNA Methylation |
|
DAA2458 |
hypothetical protein LOC146433 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
IL34 |
27.7% Decrease DNA Methylation |
|
DAA2439 |
hypothetical protein LOC283598 increases with age |
Molecular |
mesenchymal stem cell |
Human |
C14orf177 |
42.5% Increase DNA Methylation |
|
DAA2463 |
Level of miR-19a decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR19A |
40.7% Decrease miRNA Level |
|
DAA2462 |
Level of miR-519d decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR519D |
44.7% Decrease miRNA Level |
|
DAA2445 |
L-pipecolic acid oxidase increases with age |
Molecular |
mesenchymal stem cell |
Human |
PIPOX |
32.2% Increase DNA Methylation |
|
DAA2449 |
microfibrillar associated protein 5 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MFAP5 |
46.4% Decrease DNA Methylation |
|
DAA2434 |
nerve growth factor; beta polypeptide precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
NGF |
22.5% Decrease DNA Methylation |
|
DAA2013 |
Number and differentiation potential of adipose tissue-derived stem cells declines with age |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2456 |
PDZ and LIM domain 2 isoform 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PDLIM2 |
43.9% Increase DNA Methylation |
|